- Each component assayed to ≥99% (HPLC); per-lot COA on request
- Certificate of analysis tied to your lot number
- Tracked EU delivery, dispatched the next working day
BPC-157 + TB-500 (Wolverine Blend)
BPC-157 and TB-500 pre-combined in one lyophilised research vial (“Wolverine” blend)
In stock2 formats available
€110Range €110 – €195
This listing is currently unavailable. Contact us and we will tell you when it is back or suggest an equivalent.
Ask about this listing or request its COA- FormCo-lyophilized powder blend, sealed glass vial
- Research areasSoft-tissue repair, tendon and ligament models, cell migration, angiogenesis
For laboratory research use only. Sold exclusively for in-vitro laboratory research by qualified professionals. Not for human or veterinary use, and not a medicine, food, cosmetic or dietary supplement. Terms and Conditions
Overview
Key facts
Nicknamed “Wolverine”, this blend packs two of the most-researched peptides in repair models into a single lyophilised vial: BPC-157, the 15-residue fragment of a gastric protective protein, and TB-500, the acetylated heptapeptide carrying thymosin beta-4's actin-binding region.
- Purity
- ≥99% by HPLC per component; lot-matched COA available
- Form
- Co-lyophilized powder blend, sealed glass vial
- Storage
- −20 °C, sealed and protected from light and moisture
- Available sizes
- 10 mg · (5/5) · 20 mg · (10/10)
For research use only. Not for human consumption.
Nicknamed “Wolverine”, this blend packs two of the most-researched peptides in repair models into a single lyophilised vial: BPC-157, the 15-residue fragment of a gastric protective protein, and TB-500, the acetylated heptapeptide carrying thymosin beta-4's actin-binding region. They are present in equal amounts — 5 mg of each in the 10 mg vial and 10 mg of each in the 20 mg vial.
A pre-blended vial is the practical choice when a protocol needs both sequences at a set ratio and reconstituting them separately would mean extra handling, more stopper punctures and one more opportunity for pipetting errors. We synthesise each peptide individually, purify it by reversed-phase HPLC to ≥99%, and only then combine and co-lyophilise them — so the certificate of analysis reports the two components separately rather than the blend as one figure.
The pairing attracts interest because both sequences are studied in the same injury models via different mechanisms: BPC-157 in gut and tendon work with an angiogenic angle, TB-500 in cell-migration and cytoskeleton research. Published data have not yet established whether the combination does anything beyond what each achieves alone. Supplied for laboratory research only.
What sets this listing apart
BPC-157 + TB-500 combines BPC-157 and TB-500 in one listing (10/20 mg). Components that are also sold on their own are linked below, each with its own specification and COA.
Same compound, other listings
Specifications
Supply & purity
- Form
- Co-lyophilized powder blend, sealed glass vial
- Purity
- ≥99% by HPLC per component; lot-matched COA available
- Available sizes
- 10 mg total (5 mg / 5 mg), 20 mg total (10 mg / 10 mg)
Handling & storage
- Storage (lyophilized)
- −20 °C, sealed and protected from light and moisture
Additional detail
- Components
- BPC-157 and TB-500 (thymosin beta-4 17–23 fragment)
- Blend ratio
- 1:1 by mass
- BPC-157 CAS number
- 137525-51-0
- BPC-157 formula and mass
- C62H98N16O22, 1419.55 g/mol
- BPC-157 sequence
- Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
- TB-500 CAS number
- 885340-08-9
- TB-500 formula and mass
- C38H68N10O14, 889.02 g/mol
- TB-500 sequence
- Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln
- Research areas
- Soft-tissue repair, tendon and ligament models, cell migration, angiogenesis
Questions about BPC-157 + TB-500 (Wolverine Blend)
What is the “Wolverine” blend?
One lyophilised vial holding BPC-157 and TB-500 in equal parts — 5 mg of each in the 10 mg size, 10 mg of each in the 20 mg size — so you reconstitute a single vial rather than making up two.
Is each peptide tested on its own?
Yes. Both sequences are synthesised and purified to ≥99% by reversed-phase HPLC before they are combined, and the certificate of analysis gives purity and identity for BPC-157 and TB-500 separately, not a single value for the mixture.
Can I alter the ratio?
Not inside the vial. The peptides are co-lyophilised at a fixed 1:1 ratio, so diluting the solution changes both concentrations equally. If your study needs to vary the proportion, order BPC-157 and TB-500 as individual vials.
Related
